Please provide your email address to receive an email when new articles are posted on . There are two FDA-approved medications for PTSD, both selective serotonin reuptake inhibitors. The FDA has not ...
The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news ...
When the Food and Drug Administration (FDA) declined to approve MDMA-assisted psychotherapy as a treatment for post-traumatic stress disorder (PTSD) last year, the details of its objections were not ...
Credit: Getty Images. Significant factors limit MDMA’s ability to be used in the treatment of post-traumatic stress disorder. Significant factors limit MDMA’s ability to be used in the treatment of ...
Today, the FDA issued a complete response letter (CRL) for midomafetamine capsules (MDMA) in combination with assisted therapy (MDMA-AT) for adults living with posttraumatic stress disorder (PTSD).
It's a crucial moment for the future of psychedelic medicine. By August 11, the Food and Drug Administration is expected to decide whether MDMA – the chemical found in ecstasy or molly – can be ...
Psychedelic and MDMA-assisted therapies show promise for mental health conditions but face safety concerns outside clinical settings. The FDA rejected an MDMA-assisted therapy application, ...
In what could be a pivotal moment for the future of psychedelic medicine, the Food & Drug Administration (FDA) is weighing a decision to approve MDMA-AT, also known as ecstasy or molly, to treat ...
The Defense Department is committing two $4.9 million grants to study the effects of MDMA on post-traumatic stress disorder, one of which will enroll active-duty troops as subjects. Pictured is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results